Stay updated on PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is displayed, replacing the previous v3.4.1. This appears to be a backend/UI maintenance update with no visible changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:25:20.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Minor version update from Revision: v3.4.0 to v3.4.1 with no visible changes to core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:31:13.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Show glossary and minor copy changes (including a Revision: v3.4.0 note and capitalization tweaks) were added; these changes do not affect study data or core functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T21:18:15.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T04:30:35.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry were removed.
    Difference
    0.1%
    Check dated 2025-12-23T21:55:29.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The Publications section text was updated to clarify that publications are provided voluntarily by the person entering information about the study, and the revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:45:05.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.